Beatrix is founder and CEO/CSO of Doderm, which is has led since 2013. An expert in immunotherapies as well as microbiome and allergy research, she has a PhD from the Max Planck Institute of Biochemistry. During various international activities, including at Stanford University and Utrecht University, she has been researching therapeutic antibodies and headed the antibody development laboratory at TRION Research. She has a strong European network in the veterinarian and human research and business community, and has experience in project management, management consulting and business development.